The position of psychooncology in contemporary psychiatry;Miejsce psychoonkologii we współczesnej psychiatrii

Psychiatria Polska

Volumn 42, Issue 5, 2008, Pages 749-765

  Jabłoński, Marcin ^a   Furgał, Mariusz ^b   Dudek, Dominika ^b   Ziȩba, Andrzej ^b  

^a Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Adaptive strategies; Psychooncology; Stress

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; CLINICAL ASSESSMENT; DEPRESSION; DISEASE COURSE; DISTRESS SYNDROME; HOLISTIC CARE; HUMAN; ONCOLOGY; PREDICTOR VARIABLE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOONCOLOGY; PSYCHOTHERAPY; REVIEW; SOCIAL ASPECT; ADAPTIVE BEHAVIOR; INTERDISCIPLINARY COMMUNICATION; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PSYCHIATRY; PUBLIC RELATIONS;

ADAPTATION, PSYCHOLOGICAL; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERPROFESSIONAL RELATIONS; MEDICAL ONCOLOGY; NEOPLASMS; PSYCHIATRY; RESEARCH DESIGN; SICK ROLE;

EID: 66349102270     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Grassi L, Biancosino B, Marmai L, Rossi E, Sabato S. Psychological factors affecting oncology conditions. Adv. Psychosom. Med. 2007; 28: 57-71.
2. Edman L, Larsen J, Hagglund H, Gardulf A. Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation. Eur. J. Cancer Care 2001; 10: 124-130. (Pubitemid 33699418)
3. Holland JC. Managing depression in the patient with cancer. Cancer J. Clin. 1987; 37: 366-371.
4. Loberiza FRJr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J. Clin. Oncol. 2002; 15: 2118-2126.
5. Parker PA, Baile WF, de Moor C, Cohen L. Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncol. 2003; 12: 183-193. (Pubitemid 36362046)
6. Redd WH, Silberfarb PM, Andersen BL, Andrykowski MA, Bovbjerg DH, Burish TG, Carpenter PJ, Cleeland C, Dolgin M, Levy SM. Physiologic and psychobehavioral research in oncology. Cancer 1991; 1: 813-822.
7. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marr. Transplant. 1993; 11: 319-327.
8. Wettergren L, Langius A, Bjorkholm M, Bjorvell H. Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation - a prospective study. Bone Marr. Transplant. 1997; 20: 497-502.
9. Andersen BL. Surviving cancer. Cancer 1994; 15: 1484-1495. (Pubitemid 24301810)
10. Krzakowski M, red. Onkologia kliniczna. Tom I i II. Warszawa: Wydawnictwo Medyczne "Borgis"; 2001.
11. Engel GL. The need for a new medical model: A challenge for biomedicine. Science 1977; 196: 129-136. (Pubitemid 8067676)
12. Broom B. Meaning-full disease. London Karnac; 2007: 39-40.
13. Goldberg JG. Psychotherapeutic treatment of cancer patients. New York: The Free Press, 1981.
14. Juczyński Z. Psychoonkologia jako dziedzina badań i praktyki klinicznej. Psychoonkol. 2002; 6: 71-75.
15. Blumberg EM, West PM, Ellis FW. A possible relationship between psychological factors and human cancer. Psychosom. Med. 1954; 16: 227-286.
16. Thomas CB, Duszynski DR. Closeness to parents and family constellation in a prospective study of fife disease states: suicide, mental illness, malignant tumor, hypertension and coronary heart disease. The John Hopkins Med. J. 1974; 134: 251-270.
17. Bacon CL, Renneker R, Cutler M. A psychosomatic survey of cancer of the breast. Psychosom. Med. 1952; 14: 453-460.
18. Greer S, Morris T. Psychological attributes of women who develop brest cancer. A controlled study. J. Psychosom. Res. 1975; 19: 147-153.
19. Derogatis LR, Abeloff MD. Cancer and the mind: how are they conected. Science 1978; 200: 1363-1368.
20. Field PB. Mortality rates and agression management indices. J. Health Hum. Behav. 1963; 4: 121-126.
21. Israel L. Conquering cancer. New York: Vintage Books; 1979.
22. Wirsching M. Wokół raka - pacjent, rodzina, opieka medyczna. Gdańsk: Gdańskie Wydawnictwo Psychologiczne; 1994.
23. Seligman M. Optymizmu można siȩ nauczyć. Poznań: Media Rodzina of Poznań; 1993.
24. Klopfer B. Psychological variables in human cancer. J. Project. Techn. 1957; 21: 331-340.
25. Stavraky KM, Buck CN, Lott JS, Worklin JM. Psychological factors in the outcome of human cancer. Psychosom. Res. 1968; 12: 251-259.
26. Derogatis LR, Abeloff MD, McBeth CD. Cancer patients and their physicians in the perception of psychological symptoms. Psychosom. Med. 1962; 17: 197-201.
27. Davies RK, Mc Kegney F, Kimball CP. Organic factors and psychological adjustment in advanced cancer patients. Psychosom. Med. 1973; 17: 197-201.
28. Persky VW, Kempthorne-Rawson J, Shekelle RB. Personality and risk of cancer. Psychosom. Med. 1987; 49: 435-449.
29. Zonderman AB, Costa PT, McCrae RR. Depression as risk for cancer morbidity and mortality in nationally representative sample. J. Am. Med. Assoc. 1989; 262: 1191-1195.
30. Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000; 14: 1326-1327.
31. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 2000; 24: 2101-2107.
32. Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Messe MR. Patient noncompliance with self-administered chemotherapy. Cancer 1990; 1: 17-22. (Pubitemid 20026803)
33. Montgomery C, Pocock M, Titley K, Lloyd K. Individual quality of life in patients with leukaemia and lymphoma. Psychooncol. 2002; 11: 239-243. (Pubitemid 34624554)
34. Montgomery C, Pocock M, Titley K, Lloyd K. Predicting psychological distress in patients with leukaemia and lymphoma. J. Psychosom. Res. 2003; 54: 289-292.
35. Schroevers MJ, Ranchor AV, Sanderman R. The role of social support and self-esteem in the presence and course of depressive symptoms: a comparison of cancer patients and individuals from the general population. Soc. Sc. Med. 2003; 57: 375-385.
36. Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer 2002; 15: 2719-2727. (Pubitemid 34478089)
37. Wellisch DK, Centeno J, Guzman J, Belin T, Schiller GJ. Bone marrow transplantation vs. high-dose cytorabine-based consolidation chemotherapy for acute myelogenous leukemia. A long-term follow-up study of quality-of-life measures of survivors. Psychosom. 1996; 37: 144-154.
38. Maier H, Smith J. Psychological predictors of mortality in old age. J. Gerontol. 1999; 54: 44-54. (Pubitemid 29059034)
39. De Walden-Gałuszko K, red. Psychoonkologia. Biblioteka Psychiatrii Polskiej. Kraków: Komitet Redakcyjno-Wydawniczy PTP; 2000.
40. Kathol RG, Mutgi A, Williams J, Clamon G, Noyes RJr. Diagnosis of major depression in cancer patients according to four sets of criteria. Am. J. Psychiatry 1990; 147: 1021-1024. (Pubitemid 20257513)
41. Neitzert CS, Ritvo P, Dancey J, Weiser K, Murray C, Avery J. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marr. Transplant. 1998; 22: 409-422.
42. Molassiotis A. A conceptual model of adaptation to illness and quality of life for cancer patients treated with bone marrow transplants. J. Advanc. Nurs. 1997; 26: 572-579.
43. Falek A, Britton S. Phases in coping: the hypothesis and its implications. Soc. Biol. 1974; 21: 1-7.
44. Glaser BA. The social loss of aged dying patients. Gerontol. 1966; 6: 77-80.
45. Pattison EM. The experience of dying. Am. J. Psychother. 1967; 21: 32-43.
46. Taylor SE. Health psychology. New York: McGraw-Hill; 2003.
47. Liss-Levinson WS. Reality perspectives for psychological services in a hospice program. Am. Psychol. 1982; 37: 1266-1270.
48. Schulz R, Aderman D. Clinical research and the stages of dying. Omega 1974; 5: 137-143.
49. Sȩdek G. Jak ludzie radza̧ sobie z sytuacjami, na które nie ma rady? W: Kofta M, Szuster T, red. Złudzenia, które pomagaja̧ żyć. Warszawa: PWN; 1991, s. 289-317.
50. Heszen-Niejodek I. Teoria stresu psychologicznego i radzenia sobie. Psychologiczne problemy chorych somatycznie. W: Strelau J, red. Psychologia, podrȩcznik akademicki. Gdańsk: Gdańskie Wydawnictwo Psychologiczne; 2000.
51. Worden JW, Weisman AD. Psychosocial components of lagtime in cancer diagnosis. J. Psychosom. Res. 1975; 19: 69-79.
52. Breitbart W, Suicide W, Holland J, Rowland J, red. Handbook of psychooncology. New York: Oxford University Press; 1990, 291-300.
53. Łosiak W. Dynamika emocji i radzenia sobie w stresie psychologicznym, badania pacjentów chirurgicznych, Rozprawy habilitacyjne nr 273. Kraków: Wydawnictwo Uniwersytetu Jagiellońskiego; 1994.
54. Moos R. Coping with physical illness. New York: Plenum; 1977.
55. Heszen-Niejodek I, Wrześniewski K. Udział psychologii w rozwia̧zywaniu problemów zdrowia somatycznego. W: Strelau J, red. Psychologia, podrȩcznik akademicki. Gdaņsk: Gdaņskie Wydawnictwo Psychologiczne; 2000.
56. Dolbeault S, Szporn A, Holland JC. Psycho-oncology: where have we been? Where are we going? Eur. J. Cancer 1999; 35: 1554-1558. (Pubitemid 29454526)
57. Majkowicz M. Wybrane zagadnienia metodologii i technik badawczych w psychoonkologii. W: De Walden-Gałuszko K, red. Psychoonkologia. Biblioteka Psychiatrii Polskiej. Kraków: Komitet Redakcyjno-Wydawniczy PTP; 2000.
58. Stephen JE, Rahn M, Verhoef M, Leis A. What is the state of the evidence on the mind-cancer survival question, and where do we go from here? A point of view. Support. Care Cancer 2007; 15: 923-930. (Pubitemid 350104588)
59. Molassiotis A, Morris PJ. Suicide and suicidal ideation after marrow transplantation. Bone Marr. Transplant. 1997; 19: 87-90.
60. Schulz-Kindermann F, Hennings U, Ramm G, Zander AR, Hasenbring M. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marr. Transplant. 2002; 29: 341-351.
61. Molassiotis A, Coventry PA, Stricker CT, Clements C, Eaby B, Velders L, Rittenberg C, Gralla RJ. Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J. Pain Sympt. Managem. 2007; 34: 148-159
62. Kornblith AB, Herndon JE 2nd, Silverman LR, Demakos EP, Odchimar-Reissig R, Holland JF, Powell BL, DeCastro C, Ellerton J, Larson RA, Schiffer CA, Holland JC. Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study. J. Clin. Oncol. 2002; 15: 2441-2452.